Zobrazeno 1 - 10
of 213
pro vyhledávání: '"Hiroko BANDO"'
Autor:
Keita Sasaki, Junki Mizusawa, Hiroko Bando, Kenichi Nakamura, Tomoko Kataoka, Hiroshi Katayama, Haruhiko Fukuda, Hisato Hara
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-9 (2024)
Abstract Background Poor patient accrual can delay reporting of clinical trials and, consequently, the development of new treatments. For reducing the risk of additional resource requirements, a method for setting planned accrual periods with minimal
Externí odkaz:
https://doaj.org/article/119968e2b2564c9e966ec6c41f0fc6c8
Autor:
Shin Takahashi, Nobuaki Sato, Kouji Kaneko, Norikazu Masuda, Masaaki Kawai, Hisashi Hirakawa, Tadashi Nomizu, Hiroji Iwata, Ai Ueda, Takashi Ishikawa, Hiroko Bando, Yuka Inoue, Takayuki Ueno, Shinji Ohno, Makoto Kubo, Hideko Yamauchi, Masahiro Okamoto, Eriko Tokunaga, Shunji Kamigaki, Kenjiro Aogi, Hideaki Komatsu, Masahiro Kitada, Yasuaki Uemoto, Tatsuya Toyama, Yutaka Yamamoto, Toshinari Yamashita, Takehiro Yanagawa, Hiroko Yamashita, Yoshiaki Matsumoto, Masakazu Toi, Minoru Miyashita, Takanori Ishida, Fumiyoshi Fujishima, Satoko Sato, Takuhiro Yamaguchi, Fumiaki Takahashi, Chikashi Ishioka
Publikováno v:
Translational Oncology, Vol 48, Iss , Pp 102060- (2024)
The TP53 signature is considered a predictor of neoadjuvant chemotherapy (NAC) response and prognostic factor in breast cancer. The objective of this study was to confirm TP53 signature can predict pathological complete response (pCR) and prognosis i
Externí odkaz:
https://doaj.org/article/74d2b36fc35b41b88125efdc9ac30b6a
Autor:
Yurina Yanase, Hiroko Bando, Riko Sato, Tomohei Matsuo, Aya Ueda, Mai Okazaki, Sachie Hashimoto, Akiko Iguchi-Manaka, Hisato Hara
Publikováno v:
Journal of Medical Case Reports, Vol 18, Iss 1, Pp 1-6 (2024)
Abstract Background As an oncologic emergency related to abnormalities in calcium metabolism, hypercalcemia associated with paraneoplastic syndrome and bone metastases is well known. Meanwhile, the incidence of hypocalcemia is low, except in cases as
Externí odkaz:
https://doaj.org/article/104e13d3f2af49b1a6904635dfa4ea2e
Autor:
Masataka Sawaki, Naruto Taira, Yukari Uemura, Tsuyoshi Saito, Shinichi Baba, Kokoro Kobayashi, Hiroaki Kawashima, Michiko Tsuneizumi, Noriko Sagawa, Hiroko Bando, Masato Takahashi, Miki Yamaguchi, Tsutomu Takashima, Takahiro Nakayama, Masahiro Kashiwaba, Toshiro Mizuno, Yutaka Yamamoto, Hiroji Iwata, Tatsuya Toyama, Koichiro Tsugawa, Takuya Kawahara, Hirofumi Mukai
Publikováno v:
Breast, Vol 66, Iss , Pp 245-254 (2022)
Purpose: To gauge the effects of treatment practices on prognosis for older patients with HER2-positive early breast cancer, particularly to determine whether adjuvant trastuzumab alone can offer benefit over no adjuvant therapy. This is a prospectiv
Externí odkaz:
https://doaj.org/article/a945b7265854493eb752770a4643139b
Autor:
Takayuki Ueno, Shigehisa Kitano, Norikazu Masuda, Daiki Ikarashi, Makiko Yamashita, Tomohiro Chiba, Takayuki Kadoya, Hiroko Bando, Takashi Yamanaka, Shoichiro Ohtani, Shigenori Nagai, Takahiro Nakayama, Masato Takahashi, Shigehira Saji, Kenjiro Aogi, Ravi Velaga, Kosuke Kawaguchi, Satoshi Morita, Hironori Haga, Shinji Ohno, Masakazu Toi
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-10 (2022)
Abstract Background Triple-negative breast cancer (TNBC) is a biologically diverse disease, with characteristics such as homologous recombination deficiency (HRD), gene mutation, and immune reactions. Japan Breast Cancer Research Group 22 is a multic
Externí odkaz:
https://doaj.org/article/5711388d449949039bda369d7ffea37a
Autor:
Michiyo Mizuno, Ikuko Chiba, Toru Mukohara, Miki Kondo, Kazushi Maruo, Tomohiro Ohigashi, Miki Naruo, Yoshihiro Asano, Tatsuya Onishi, Hiroshi Tanabe, Rieko Muta, Saori Mishima, Susumu Okano, Masami Yuda, Ako Hosono, Yuri Ueda, Hiroko Bando, Hiroya Itagaki, Carol Estwing Ferrans, Tetsuo Akimoto
Publikováno v:
Contemporary Clinical Trials Communications, Vol 30, Iss , Pp 101035- (2022)
Background: The aim of the trial is to evaluate the effectiveness of interventions provided by online support program apps, adopting health-related quality of life (HR-QOL) scores as indicators. Methods: The design is as an open, randomized, parallel
Externí odkaz:
https://doaj.org/article/f42c280edfd14d53b2fc8ca342384431
Autor:
Hirotoshi Iihara, Mototsugu Shimokawa, Masakazu Abe, Mitsue Saito, Toru Mukohara, Hironobu Hashimoto, Rie Ozeki, Hiroko Bando, Toshinobu Hayashi, Hitoshi Kawazoe, Masayo Komoda, Takako Yanai Takahashi
Publikováno v:
BMJ Open, Vol 12, Iss 3 (2022)
Introduction Triple antiemetic therapy with neurokinin-1 receptor antagonist, 5-hydroxytryptamine type 3 receptor antagonist, and dexamethasone has been widely recommended for high emetogenic chemotherapeutic (HEC) agents and regimens, including anth
Externí odkaz:
https://doaj.org/article/43e5a77aedcb4def83629d8a622a26e8
Autor:
Azusa Terasaki, Hiromi Kurokawa, Hiromu Ito, Yoshiki Komatsu, Daisuke Matano, Masahiko Terasaki, Hiroko Bando, Hisato Hara, Hirofumi Matsui
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 24, p 9522 (2020)
Hyperthermia (HT) treatment is a noninvasive cancer therapy, often used with radiation therapy and chemotherapy. Compared with 37 °C, 42 °C is mild heat stress for cells and produces reactive oxygen species (ROS) from mitochondria. To involve subse
Externí odkaz:
https://doaj.org/article/ec4163df3188470aa9f0434b0934f018
Autor:
Akiko Iguchi-Manaka, Genki Okumura, Hiroshi Kojima, Yukiko Cho, Rei Hirochika, Hiroko Bando, Toyomi Sato, Hiroyuki Yoshikawa, Hisato Hara, Akira Shibuya, Kazuko Shibuya
Publikováno v:
PLoS ONE, Vol 11, Iss 4, p e0152982 (2016)
Emerging evidence suggests that DNAM-1 (CD226) play an important role in the recognition of tumor cells and their lysis by cytotoxic T lymphocytes (CTL) and NK cells. Although the DNAM-1 ligand CD155 is ubiquitously expressed in various tissues, many
Externí odkaz:
https://doaj.org/article/47dac93118794e0d9aa7443efd86b222
Autor:
Atsuko SUGIYAMA, Kazuki UTSUNOMIYA, Hayato Okumiya, Katsuhiko FUJIMOTO, Yuka SHIMOMURA, Masaru SANUKI, Keitaro KUME, Takahiro YANO, Rina KAGAWA, Hiroko BANDO
Publikováno v:
Studies in Health Technology & Informatics; 2024, Vol. 316, p1719-1723, 5p